Bain Capital’s $3.12bn private equity deal with Evident was the medical devices industry’s biggest cross border deal of Q3 2022 as cross border deals worth $8.1bn were announced globally in the quarter, according to GlobalData’s deals database.
The value marked an increase of 11.9% over the previous quarter and a drop of 32.6% when compared with the last four-quarter average of $11.97bn.
In terms of number of cross border deals, the sector saw a drop of 26.90% with 144 deals in Q3 2022 against the average of 197.00 deals in the last four-quarters.
In value terms, Europe led the activity with cross border deals worth $3.26bn.
